Cardiovascular Systems Inc (NASDAQ:CSII) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. Cardiovascular Systems Inc is a medical technology company developing solutions for vascular and coronary disease. It treats patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. Cardiovascular Systems Inc has a market cap of $1.76 billion; its shares were traded at around $50.35 with a P/E ratio of 1007.00 and P/S ratio of 7.20. GuruFocus has detected 1 severe warning sign with Cardiovascular Systems Inc. .
For the last quarter Cardiovascular Systems Inc reported a revenue of $68.2 million, compared with the revenue of $59.15 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $248.0 million, an increase of 14.3% from last year. For the complete 30-year financial data, please go here.. For the last five years Cardiovascular Systems Inc had an average revenue growth rate of 11% a year.
The reported loss per diluted share was 1 cents for the year, compared with the earnings per share of $-0.06 in the previous year. The Cardiovascular Systems Inc had an operating margin of -0.33%, compared with the operating margin of 1.03% a year before. The 10-year historical median operating margin of Cardiovascular Systems Inc is -19.78%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, Cardiovascular Systems Inc has the cash and cash equivalents of $74.2 million, compared with $116.3 million in the previous year. The long term debt was $21.0 million, compared with $21.1 million in the previous year. Cardiovascular Systems Inc has a financial strength rank of 7 (out of 10).
At the current stock price of $50.35, Cardiovascular Systems Inc is traded at 82.4% premium to its historical median P/S valuation band of $27.60. The P/S ratio of the stock is 7.20, while the historical median P/S ratio is 3.96. The stock gained 30.81% during the past 12 months.
Directors and Officers Recent Trades:
- General Counsel & Corp. Sec. Alexander Rosenstein sold 1,136 shares of CSII stock on 08/15/2019 at the average price of $47.04. The price of the stock has increased by 7.04% since.
- Chief Compliance Officer Sandra Sedo sold 882 shares of CSII stock on 08/15/2019 at the average price of $47.06. The price of the stock has increased by 6.99% since.
For the complete 20-year historical financial data of CSII, click here.
This article first appeared on GuruFocus.
- Warning! GuruFocus has detected 3 Warning Sign with CSII. Click here to check it out.
- CSII 15-Year Financial Data
- The intrinsic value of CSII
- Peter Lynch Chart of CSII